Zobrazeno 1 - 10 of 13 pro vyhledávání: '"Acute Leukemia Working Party of the European Society for Blood and"'
1
Akademický článek
Post-transplant cyclophosphamide after matched sibling, unrelated and haploidentical donor transplants in patients with acute myeloid leukemia: a comparative study of the ALWP EBMT
Autor: Jaime Sanz, Jacques-Emmanuel Galimard, Myriam Labopin, Boris Afanasyev, Emanuele Angelucci, Fabio Ciceri, Didier Blaise, Jan J. Cornelissen, Ellen Meijer, J. L. Diez-Martin, Yener Koc, Montserrat Rovira, Luca Castagna, Bipin Savani, Annalisa Ruggeri, Arnon Nagler, Mohamad Mohty, Acute Leukemia Working Party of the European Society for Blood and Marrow Transplantation (EBMT)
Publikováno v: Journal of Hematology & Oncology, Vol 13, Iss 1, Pp 1-13 (2020)
Abstract Background The use of post-transplant cyclophosphamide (PTCy) is highly effective in preventing graft-versus-host disease (GVHD) in the haploidentical (Haplo) transplant setting and is being increasingly used in matched sibling (MSD) and mat
Externí odkaz: https://doaj.org/article/c5cf9464d84340149bef06673faa4d2f
Zobrazit plný text záznamu
2
Hematopoietic stem cell transplantation for adults with relapsed acute promyelocytic leukemia in second complete remission
Autor: Sanz, Jaime, Labopin, Myriam, Sanz, Miguel A, Aljurf, Mahmoud, Sousa, Aida Botelho, Craddock, Charles, Zuckerman, Tsila, Labussiere-Wallet, Helene, Campos, Antonio, Grillo, Giovanni, Ozkurt, Zubeyde Nur, Cornelissen, J J, Remenyi, Peter, Martino, Massimo, Porras, Rocio Parody, Nagler, Arnon, Gorin, Norbert-Claude, Mohty, Mohamad, Acute Leukemia Working Party of the European Society for Blood and, Marrow Transplantation (EBMT)
Publikováno v: BONE MARROW TRANSPLANTATION
r-IIS La Fe. Repositorio Institucional de Producción Científica del Instituto de Investigación Sanitaria La Fe
instname
We retrospectively compared outcomes of a large series of adult patients with APL in CR2 receiving alloHSCT (n = 228) or autoHSCT (n = 341) reported to the European Society for Blood and Marrow Transplantation from January 2004 to December 2018. The
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=RECOLECTA___::bc986abf13161e34c996ee75d002dc6a
https://fundanet.iislafe.san.gva.es/publicaciones/ProdCientif/PublicacionFrw.aspx?id=13543
Zobrazit plný text záznamu
3
Distinct factors determine the kinetics of disease relapse in adults transplanted for acute myeloid leukaemia
Autor: Craddock, C, Versluis, J, Labopin, M, Socie, G, Huynh, A, Deconinck, E, Volin, L, Milpied, N, Bourhis, JH, Rambaldi, A, Chevallier, P, Blaise, D, Manz, M, Vellenga, E, Vekemans, MC, Maertens, J, Passweg, J, Vyas, P, Schmid, C, Löwenberg, B, Ossenkoppele, G, Mohty, M, Cornelissen, JJ, Nagler, A, HOVON‐SAKK, Acute Leukemia Working Party of the European Society for Blood and Marrow Transplantation and
Publikováno v: Journal of Internal Medicine, 283(4), 371-379. Wiley
Journal of Internal Medicine, Vol. 283, no. 4, p. 371-379 (2018)
Journal of Internal Medicine, 283(4), 371-379. Wiley-Blackwell Publishing Ltd
Background. Disease recurrence remains the major cause of death in adults with acute myeloid leukaemia (AML) treated using either intensive chemotherapy (IC) or allogenic stem cell transplantation (allo-SCT).Aims. The timely delivery of maintenance d
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::eb986cf16885abd26b74d07751289dff
https://pubmed.ncbi.nlm.nih.gov/29214689
Zobrazit plný text záznamu
4
A comparison between allogeneic stem cell transplantation from unmanipulated haploidentical and unrelated donors in acute leukemia
Autor: Simona Piemontese, F. Ciceri, M. Labopin, W. Arcese, S. Kyrcz-Krzemien, S. Santarone, H. Huang, D. Beelen, N. C. Gorin, C. Craddock, Z. Gulbas, A. Bacigalupo, M. Mohty, A. Nagler, on behalf of the Acute Leukemia Working Party of the European Society for Blood and Marrow Transplantation (EBMT)
Publikováno v: Journal of Hematology and Oncology
Journal of Hematology and Oncology, BioMed Central, 2017, 10, pp.24. ⟨10.1186/s13045-017-0394-2⟩
Journal of Hematology & Oncology
Journal of Hematology & Oncology, Vol 10, Iss 1, Pp 1-8 (2017)
Journal of Hematology and Oncology, 2017, 10, pp.24. ⟨10.1186/s13045-017-0394-2⟩
Background In the absence of a HLA-matched related or matched unrelated donor, allogeneic stem cell transplantation (allo-SCT) from mismatched unrelated donors or haploidentical donors are potential alternatives for patients with acute leukemia with
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::cddcf1814096836e6ba0e9669abe6708
https://duepublico.uni-due.de/servlets/DocumentServlet?id=44354
Zobrazit plný text záznamu
5
T-cell-replete haploidentical transplantation versus autologous stem cell transplantation in adult acute leukemia: a matched pair analysis
Autor: Gorin NC, Labopin M, Piemontese S, Arcese W, Santarone S, Huang H, Meloni G, Ferrara F, Beelen D, Sanz M, Bacigalupo A, Ciceri F, Mailhol A, Nagler A, Mohty M, Acute Leukemia Working Party of the European Society for Blood and Marrow Transp
Publikováno v: HAEMATOLOGICA
r-IIS La Fe. Repositorio Institucional de Producción Científica del Instituto de Investigación Sanitaria La Fe
instname
Adult patients with acute leukemia in need of a transplant but without a genoidentical donor are usually considered upfront for transplantation with stem cells from any other allogeneic source, rather than autologous stem cell transplantation. We use
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=RECOLECTA___::070c4d947f2c1491f4ff3a657bf1c33c
https://fundanet.iislafe.san.gva.es/publicaciones/ProdCientif/PublicacionFrw.aspx?id=1304
Zobrazit plný text záznamu
6
Akademický článek
Leukemia relapse following unmanipulated haploidentical transplantation: a risk factor analysis on behalf of the ALWP of the EBMT
Autor: Simona Piemontese, Ariane Boumendil, Myriam Labopin, Christoph Schmid, Fabio Ciceri, William Arcese, Yener Koc, Zafar Gulbas, Johanna Tischer, Benedetto Bruno, Depei Wu, Didier Blaise, Dietrich Beelen, Giuseppe Irrera, Annalisa Ruggeri, Mohamed Houhou, Mohamad Mohty, Arnon Nagler, on behalf of the Acute Leukemia Working Party of the European Society for Blood and Marrow Transplantation (EBMT)
Publikováno v: Journal of Hematology & Oncology, Vol 12, Iss 1, Pp 1-11 (2019)
Abstract Background As information on incidence, risk factors, and outcome of acute leukemia (AL) relapse after unmanipulated haploidentical stem cell transplantation (haplo-SCT) is scarce, a retrospective registry study was performed by the Acute Le
Externí odkaz: https://doaj.org/article/7ec10985c5b14c0890459b8a40c50775
Zobrazit plný text záznamu
8
Akademický článek
Postremission Consolidation by Autologous Hematopoietic Cell Transplantation (HCT) for Acute Myeloid Leukemia in First Complete Remission (CR) and Negative Implications for Subsequent Allogeneic HCT in Second CR: A Study by the Acute Leukemia Working Party of the European Society for Blood and Marrow Transplantation (EBMT).
Autor: Passweg JR; Division of Hematology, University Hospital Basel, Basel, Switzerland. Electronic address: jakob.passweg@usb.ch., Labopin M; Department of Hematology and Cell Therapy, Institut National de la Santé et de la Recherche Médicale (INSERM) UMRs 938, Hopital Saint Antoine Assistance Publique-Hopitaux de Paris, Paris Sorbonne University, Paris, France., Christopeit M; University Medical Center Hamburg-Eppendorf, Hamburg, Germany., Cornelissen J; Department of Hematology, Erasmus MC Cancer Institute, University Medical Center, Rotterdam, Netherlands., Pabst T; Department of Medical Oncology, University Hospital, Bern, Switzerland., Socié G; Department of Hematology-BMT, Hopital St. Louis, Paris France., Russel N; Department of Haematology, Nottingham City Hospital, Nottingham University, Nottingham, UK., Yakoub-Agha I; CHU de Lille, LIRIC, INSERM U995, université de Lille, Lille, France., Blaise D; Programme de Transplantation & Therapie Cellulaire Centre de Recherche en Cancérologie de Marseille Institut Paoli Calmettes, Marseille, France., Gedde-Dahl T; Department of Hematology, Oslo University Hospital, Rikshospitalet, and Institute for Clinical Medicine, University of Oslo, Oslo, Norway., Labussière-Wallet H; Centre Hospitalier Lyon Sud Hospices Civils de Lyon, Lyon, France., Malladi R; Centre for Clinical Haematology, Queen Elizabeth Hospital, Birmingham, UK., Forcade E; CHU Bordeaux, Hôpital Haut-Leveque, Pessac, France., Maury S; Service d'Hématologie, Hôpital Henri Mondor, Creteil, France., Polge E; Acute Leukemia Working Party of the European Society for Blood and Marrow Transplantation (EBMT), Paris, France., Lanza F; Romagna Transplant Network, Ravenna, Italy., Gorin NC; Department of Hematology and Cell Therapy, Institut National de la Santé et de la Recherche Médicale (INSERM) UMRs 938, Hopital Saint Antoine Assistance Publique-Hopitaux de Paris, Paris Sorbonne University, Paris, France., Mohty M; Department of Hematology and Cell Therapy, Institut National de la Santé et de la Recherche Médicale (INSERM) UMRs 938, Hopital Saint Antoine Assistance Publique-Hopitaux de Paris, Paris Sorbonne University, Paris, France., Nagler A; Division of Hematology and Bone Marrow Transplantation, Chaim Sheba Medical Center, Tel-Hashomer and Sackler School of Medicine, Ramat Gan, Israel.
Publikováno v: Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation [Biol Blood Marrow Transplant] 2020 Apr; Vol. 26 (4), pp. 659-664. Date of Electronic Publication: 2019 Nov 21.
Zobrazit plný text záznamu
9
Akademický článek
Individualized prediction of leukemia-free survival after autologous stem cell transplantation in acute myeloid leukemia.
Autor: Shouval R; Hematology and Bone Marrow Transplantation Division, Chaim Sheba Medical Center at Tel HaShomer, Ramat-Gan, Israel.; Sackler School of Medicine, Tel Aviv University, Tel Aviv, Israel.; Dr. Pinchas Bornstein Talpiot Medical Leadership Program, Chaim Sheba Medical Center at Tel HaShomer, Ramat-Gan, Israel., Labopin M; Department of Hematology and Cell Therapy, Saint-Antoine Hospital, Paris, France.; Acute Leukemia Working Party of the European Society for Blood and Marrow Transplantation, Saint-Antoine Hospital, Paris, France., Gorin NC; Department of Hematology and Cell Therapy, Saint-Antoine Hospital, Paris, France.; Acute Leukemia Working Party of the European Society for Blood and Marrow Transplantation, Saint-Antoine Hospital, Paris, France., Bomze D; Hematology and Bone Marrow Transplantation Division, Chaim Sheba Medical Center at Tel HaShomer, Ramat-Gan, Israel.; Sackler School of Medicine, Tel Aviv University, Tel Aviv, Israel., Houhou M; Acute Leukemia Working Party of the European Society for Blood and Marrow Transplantation, Saint-Antoine Hospital, Paris, France., Blaise D; Transplantation and Cell Therapy Program, Marseille Cancer Research Center, Paoli Calmettes Institute, Marseille, France., Zuckerman T; Department of Hematology, Rambam Medical Center, Haifa, Israel., Baerlocher GM; Department of Hematology, Inselspital, Bern University Hospital, University of Bern, Switzerland., Capria S; Division of Hematology, Sapienza University, Rome, Italy., Forcade E; Service Hématologie Clinique et Thérapie Cellulaire, Centre Hospitalier Universitaire de Bordeaux Hôpital Haut-Leveque, Pessac, France., Huynh A; Department of Hematology, Institut Universitaire du Cancer Toulouse Oncopole, Toulouse, France., Saccardi R; Department of Cellular Therapies and Transfusion Medicine, Careggi University Hospital, Firenze, Italy., Martino M; Stem Cell Transplant Unit, Hemato-Oncology Department, Grande Ospedale Metropolitano Bianchi Melacrino Morelli, Reggio Calabria, Italy., Schaap M; Department of Hematology, Radboud University Medical Centre, Nijmegen, the Netherlands., Wu D; First Affiliated Hospital of Soochow University, Suzhou, China., Mohty M; Department of Hematology and Cell Therapy, Saint-Antoine Hospital, Paris, France.; Acute Leukemia Working Party of the European Society for Blood and Marrow Transplantation, Saint-Antoine Hospital, Paris, France., Nagler A; Hematology and Bone Marrow Transplantation Division, Chaim Sheba Medical Center at Tel HaShomer, Ramat-Gan, Israel.; Sackler School of Medicine, Tel Aviv University, Tel Aviv, Israel.; Acute Leukemia Working Party of the European Society for Blood and Marrow Transplantation, Saint-Antoine Hospital, Paris, France.
Publikováno v: Cancer [Cancer] 2019 Oct 15; Vol. 125 (20), pp. 3566-3573. Date of Electronic Publication: 2019 Jun 21.
Zobrazit plný text záznamu
10
Akademický článek
Allogeneic stem cell transplantation following relapse post autologous stem cell transplantation in adult patients with acute myeloid leukemia: A retrospective analysis of 537 patients from the Acute Leukemia Working Party of the EBMT.
Autor: Christopeit M; Department of Stem Cell Transplantation, University Medical Center Hamburg-Eppendorf, Hamburg, Germany., Labopin M; Department of Hematology and Cell Therapy, Institut National de la Santé et de la Recherche Médicale (INSERM) UMRs 938, Hopital Saint Antoine Assistance Publique-Hopitaux de Paris, Paris Sorbonne University, Paris, France.; Acute Leukemia Working Party of the European Society for Blood and Marrow Transplantation (EBMT), Paris., Gorin NC; Department of Hematology and Cell Therapy, Institut National de la Santé et de la Recherche Médicale (INSERM) UMRs 938, Hopital Saint Antoine Assistance Publique-Hopitaux de Paris, Paris Sorbonne University, Paris, France.; Acute Leukemia Working Party of the European Society for Blood and Marrow Transplantation (EBMT), Paris., Saraceni F; Hematology and Bone Marrow Transplantation, Polytechnic University of Marche-Ospedali Riuniti, Ancona, Italy., Passweg J; Hematology, University Hospital of Basel, Basel, Switzerland., Forcade E; BMT and Cell Therapy Unit, CHU Bordeaux, Pessac, France., Maertens J; Department of Hematology, University Hospital Gasthuisberg, Leuven, Belgium., Van Lint MT; Department of Haematology II, Ospedale San Martino, Genoa, Italy., Bosi A; BMT Unit Department of Hematology, Azienda Ospedaliera Universitaria Careggi, Florence, Italy., Niederwieser D; Division ofHematology, Oncology and Hemostasiology, University Hospital Leipzig, Leipzig, Germany., Ehninger G; Medizinische Klinik und Poliklinik I, Universitaetsklinikum Dresden, Dresden, Germany., Polge E; Department of Hematology and Cell Therapy, Institut National de la Santé et de la Recherche Médicale (INSERM) UMRs 938, Hopital Saint Antoine Assistance Publique-Hopitaux de Paris, Paris Sorbonne University, Paris, France.; Acute Leukemia Working Party of the European Society for Blood and Marrow Transplantation (EBMT), Paris., Mohty M; Department of Hematology and Cell Therapy, Institut National de la Santé et de la Recherche Médicale (INSERM) UMRs 938, Hopital Saint Antoine Assistance Publique-Hopitaux de Paris, Paris Sorbonne University, Paris, France., Nagler A; Acute Leukemia Working Party of the European Society for Blood and Marrow Transplantation (EBMT), Paris.; Division of Hematology and Bone Marrow Transplantation, Chaim Sheba Medical Center, Tel-Hashomer and Sackler School of Medicine, Ramat Gan, Israel.
Publikováno v: American journal of hematology [Am J Hematol] 2018 Dec; Vol. 93 (12), pp. 1532-1542. Date of Electronic Publication: 2018 Oct 26.
Zobrazit plný text záznamu

Vyhledávací nástroje:

Upřesnit hledání

Omezení vyhledávání
Plný text Recenzováno Digitální knihovna AV ČR
Zdroje